Activating mutations in the NOTCH1 gene, mutations in FBXW7 tumor suppressor, and loss of CDKN2A locus frequently occur in T-ALL (6–9), which also impact patient survival (9, 10). The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.